CorneaGen
  • SURGEON PORTAL
  • Contact Us
  • CORNEAL TISSUE
    • Tissue Overview
    • Tissue Services
      • DSAEK
      • DMEK
      • Geuder Pre-Loaded Glass Cannula
      • Ampho B
      • PKP
      • ALK
      • BrightMEM
      • FLAK
      • Non-Sterile Sclera
    • Reimbursement Assistance
    • Adverse Reaction Reporting
    • Regulatory Information
    • Request Tissue
  • Sterile Tissue
    • CTAK
    • VisionGraft
      • Glaucoma
      • Cornea
    • Sclera
    • Adverse Reaction Reporting
    • Reimbursement
    • Regulatory Information
  • Products
    • Corneal Products
      • EndoSerter-PL
      • EndoSerter
      • Cannula
      • Geuder Pre-Loaded Glass Cannula
      • Donor Punch
      • Recipient Trephine
      • Intacs
    • Products Overview
  • Innovation
  • Education
    • Educational Videos
    • Wet Labs
    • Fellows Program
  • About Us
    • Our People
    • Our Partners
    • Our Locations
    • Gift of Sight
    • Careers
    • Core Commitments
    • News & Events
Request Tissue Contact Us
CTAK Update from ASCRS 2024

CTAK Update from ASCRS 2024

May 15, 2024

Hear from Dr. Steven Greenstein and Dr. Peter Hersh from the ASCRS show floor about CTAK, the latest innovation for the treatment of keratoconus.

 

Recent Articles

  • Bernie’s Quarterly Update – July 2024

    Bernie’s Quarterly Update – July 2024

    A message from Bernie Iliakis, President & CEO of CorneaGen...

    READ MORE
  • CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes

    CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes

    CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes Advanced...

    READ MORE
  • <sub><small>Photo: Bernie Iliakis hosts a lively conversation at ASCRS Boston with <br>Edward J. Holland M.D. and Terry Kim M.D.</small></sub> <br><br> Bernie’s Quarterly Update – April 2024

    Photo: Bernie Iliakis hosts a lively conversation at ASCRS Boston with
    Edward J. Holland M.D. and Terry Kim M.D.

    Bernie’s Quarterly Update – April 2024

    A message from Bernie Iliakis, President & CEO of CorneaGen...

    READ MORE

  • CorneaGen Showcases 2023 Company Milestones and Momentum

    CorneaGen Showcases 2023 Company Milestones and Momentum Sight restoring grafts,...

    READ MORE
Navigation
  • Corneal Tissue
  • Products
  • Innovation
  • Education
  • About Us
  • Request Tissue
Helpful Information
  • Reimbursement assistance
  • Adverse reaction reporting
  • KAMRA Support
  • Careers
Legal
  • Privacy Policy
  • Terms and conditions
  • Regulatory Information
Connect
  • Contact Us
CorneaGen

©2024 CorneaGen

CorneaGen